pumping in summer? in las vegas.
Folotyn will be $100m in a few years.
Zevalin will be $300m in a few years.
We will grow Fusilev from its base of $200m/year.
We have changed Apaz protocol, we think it will be successful.
we have 165m cash. Doesnt tell the huge diff b/w AP and AR. Doesn't tell the $75m debt drawdown.
damn good hit the nail on the head same questions i had .even now hiding the details. anyone believe that raj did not know the coming drop in fusilev sales when the hedgies,shorts and everyone else knew .raj was selling ..i trust the insiders yeah they did not know
Sentiment: Strong Sell
Wake me up in 4 years and let's see where the lawsuit is and where the PPS is. Depos won't even be finished and SPPI will be trading at ???? a lot higher than in March. Tough on the damage claim when SPPI is at $80 PPS.
Management is so confident that they just made a $50 Million prepayment on the line of credit to pay it down to $25 MM even though the maturity is not until September 2014.
A small biotech with a war chest of cash, virtually no debt and with a continuing share buyback plan in place where 235,000 share were just repurchased in Q1 2013 alone.